Time
Days to earnings7
Next print2026-10-21
WindowBMO
Fiscal2026-09-30
NYSE · HEALTHCARE · DIAGNOSTICS & RESEARCH
TMO
Thermo Fisher Scientific Inc primary
662.09
Full stocks workspace →+4.14+0.6%
Street
Consensus EPS6.403
Consensus revenue12.0B
EPS high / low6.47 / 6.33 · 2.2% · n=21
Rev / avg1 / — · 6.409 / 6.405
Options
IV front29.3%
Implied move4.6%
Put/call full1.02
Put/call front0.79
Short interest
Short shares5.4M / 5.0M · +7.73%
Days to cover2.07
Avg vol · float2.6M · 368.8M
Short % float1.47%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 7 | 2026-10-21 | 662.09 | 6.403 | 29.3% | 4.6% | -2.2% | -2.4% | +7.9% | +6.4% | 6.47 / 6.33 | 2.2% | 21 | 1.02 | 1 | |
| 2026-10-09 | 8 | 2026-10-21 | 657.95 | 6.409 | 32.2% | 5.8% | +0.5% | -2.5% | +7.9% | +4.3% | 6.559 / 6.33 | 3.6% | 21 | 1.06 | 1 | |
| 2026-10-08 | 9 | 2026-10-21 | 651.76 | 6.409 | 31.7% | 6.0% | -0.1% | -3.9% | +8.1% | +2.8% | 6.559 / 6.33 | 3.6% | 21 | 1.01 | 1 | |
| 2026-10-07 | 10 | 2026-10-21 | 661.75 | 6.409 | 30.8% | 6.0% | -2.0% | -0.5% | +9.3% | +5.3% | 6.559 / 6.33 | 3.6% | 21 | 0.99 | 1 | |
| 2026-10-06 | 11 | 2026-10-21 | 656.69 | 6.409 | 30.8% | 6.2% | -3.4% | -0.3% | +8.9% | +4.4% | 6.559 / 6.33 | 3.6% | 21 | 0.99 | 1 | |
| 2026-10-05 | 12 | 2026-10-21 | 676.31 | 6.409 | 28.3% | 5.9% | -0.3% | +2.7% | +10.2% | +7.5% | 6.559 / 6.33 | 3.6% | 21 | 0.99 | 1 | |
| 2026-10-02 | 18 | 2026-10-28 | 654.93 | 6.408 | 29.3% | 7.8% | -3.0% | +0.5% | +5.9% | +4.4% | 6.559 / 6.33 | 3.6% | 22 | 0.98 | 1 | |
| 2026-10-01 | 19 | 2026-10-28 | 652.48 | 6.408 | 30.3% | 8.2% | -3.8% | -0.9% | +7.2% | +6.3% | 6.559 / 6.33 | 3.6% | 22 | 1.02 | 1 | |
| 2026-09-30 | 20 | 2026-10-28 | 675.26 | 6.408 | 30.3% | 8.4% | +1.5% | +4.1% | +12.4% | +14.6% | 6.559 / 6.33 | 3.6% | 22 | 1.01 | 1 | |
| 2026-09-29 | 21 | 2026-10-28 | 679.64 | 6.408 | 29.8% | 8.4% | +3.2% | +6.0% | +10.1% | +16.1% | 6.559 / 6.33 | 3.6% | 22 | 0.97 | 1 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| DHR primary | Danaher Corporation | 0.74 | 2026Q2 · 2026-07-21 | +5.4% | -16.0% | 179.01 | 7 · 2026-10-12 |
| MDT primary | Medtronic PLC | 0.28 | 2027Q1 · 2026-09-01 | +4.3% | +1.5% | 92.06 | 26 · 2026-10-12 |
| ISRG primary | Intuitive Surgical Inc | 0.26 | 2026Q2 · 2026-07-16 | +38.6% | -9.3% | 345.42 | 7 · 2026-10-09 |
| ABT primary | Abbott Laboratories | 0.25 | 2026Q2 · 2026-07-16 | +2.3% | +6.7% | 98.83 | 7 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-07-23 | BMO | 6.03 | +5.6% | Beat | +9.0% | -0.2% | 3.09× | +1.3% | Review |
| 2026Q1 | 2026-04-23 | BMO | 5.44 | +3.8% | Beat | -8.0% | -1.3% | 3.19× | +1.7% | Review |
| 2025Q4 | 2026-01-29 | BMO | 6.57 | +1.9% | Beat | -3.7% | +1.1% | 1.56× | -13.9% | Review |
| 2025Q3 | 2025-10-22 | BMO | 5.79 | +5.3% | Beat | -0.4% | +2.1% | 1.74× | +0.1% | Review |
| 2025Q2 | 2025-07-23 | BMO | 5.36 | +2.5% | Beat | +10.7% | -1.4% | 3.26× | -3.8% | Review |
| 2025Q1 | 2025-04-23 | BMO | 5.15 | +1.0% | Beat | +5.0% | -5.5% | 1.13× | -5.5% | Review |
| 2024Q4 | 2025-01-30 | BMO | 6.10 | +2.7% | Beat | +3.9% | +2.7% | 1.64× | -12.2% | Review |
| 2024Q3 | 2024-10-23 | BMO | 5.28 | +0.6% | Beat | -2.0% | +0.3% | 1.53× | -2.9% | Review |
| 2024Q2 | 2024-07-24 | BMO | 5.37 | +4.9% | Beat | +0.1% | +3.9% | 1.97× | +2.2% | Review |
| 2024Q1 | 2024-04-24 | BMO | 5.11 | +8.5% | Beat | +0.6% | -0.1% | 1.33× | -0.6% | Review |